Imunon, Inc. does not report net income for fiscal year 2026, so the figure is not reported on this page. Over the trailing 12 months, ending September 30, 2026, the same line adds up to a $15.0M net loss. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Imunon, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMNN Net Income by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, ending September 30, 2026, summed from the four most recent quarterly filings.
IMNN Net Income by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Imunon, Inc. financials
Frequently Asked Questions
Imunon, Inc. does not report net income for fiscal year 2026, so the figure is not reported on this page.
Imunon, Inc. (IMNN) reported a $15.0M net loss over the trailing 12 months, ending September 30, 2026, summed from the four most recent quarterly filings.
Imunon, Inc. (IMNN) reported -$3.8M in net income in Q3 2027.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Imunon, Inc. (IMNN) reported on that line in every period on record.